Glaxo Singled Out in China Probe, Smith Says

July 24 (Bloomberg) -- Andy Smith, chief investment officer at Mann Bioinvest Ltd., talks about the Chinese probe of GlaxoSmithKline Plc over allegations of bribery and corruption. He speaks with Mark Barton and Anna Edwards on Bloomberg Television's "Countdown." (Source: Bloomberg)
Samsung S6 Is a Step in the Right Direction: Cain
26:34 - March 2 -- Asia Pacific Research CEO Geoffrey Cain discusses Samsung's unveiling of the S6 and S6 Edge, featuring a three-sided screen, with Bloomberg's Rishaad Salamat on "Trending Business."
  • Modi's Budget Isn't Game Changer Investors Wanted: Iley
  • Samsung S6 an Improvement, Not `Smash Hit': IDC's Ma
  • China Stocks Favored on Monetary Policy: Chandgothia